Levosimendan

Концентрат By prescription

Cardiotonic agent

Levosimendan

Indications

Acute decompensation of severe chronic heart failure (for short-term therapy in case of ineffectiveness of standard therapy and the need to maintain myocardial contractile function).

Contraindications

Mechanical obstruction preventing ventricular filling or ventricular ejection; severe renal dysfunction (CK <30 mL/min); severe hepatic dysfunction; arterial hypotension; tachycardia; history of ventricular flutter-ventricular fibrillation; uncontrolled hypokalemia; pediatric and adolescent age less than 18 years; hypersensitivity to levosimendan.

Usage

It is intended for use only in a hospital with the necessary monitoring equipment and medical staff with experience in working with cardiotonic drugs.

The dose and duration of therapy are set individually, depending on the clinical situation. Administered by intravenous infusion.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.